Shanghai Jianxin Capital

Venture Capital China ·Founded 2010

Overview

Shanghai Jianxin Capital is a venture capital firm specializing in the healthcare industry in China. The firm focuses on investments in the pharmaceutical and health sectors, leveraging a professional biomedical investment team with extensive experience in medical and financial fields. This expertise enables them to make prospective investment layouts aligned with industry development trends, creating value for enterprises and investors. The firm's investment strategy encompasses various stages, including early-stage, late-stage, and private equity investments. Their portfolio spans multiple sectors within the healthcare industry, such as pharmaceuticals and biotechnology. Shanghai Jianxin Capital's team comprises nearly 20 professionals with backgrounds in medical institutions and financial sectors, both domestically and internationally. This diverse expertise allows them to provide comprehensive value-added services to their portfolio companies, addressing needs in product development, industrialization, management, and financial investment. Shanghai Jianxin Capital has a track record of active investments, with recent funding rounds in companies like Hegea Bio and Isabers. Their approach combines deep industry knowledge with financial acumen to support the growth and success of healthcare enterprises in China.

Investment Focus

  • Focus on healthcare industry investments
  • Interest in early-stage to private equity opportunities
  • Alignment with China's healthcare development trends

Portfolio Companies

Abbisko TherapeuticsHegea BioIsabersMeike SolarWeishi EnergyGeneCast Biotechnology

Reach Shanghai Jianxin Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Shanghai Jianxin Capital

What sectors does Shanghai Jianxin Capital invest in?

Shanghai Jianxin Capital invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in China. Shanghai Jianxin Capital is listed as a venture capital in the ConnectSafely investor database.

What stage does Shanghai Jianxin Capital invest at?

Shanghai Jianxin Capital backs companies at Early Stage and Late Stage.

Which regions does Shanghai Jianxin Capital invest in?

Shanghai Jianxin Capital invests across China.

What companies has Shanghai Jianxin Capital invested in?

Shanghai Jianxin Capital's portfolio includes Abbisko Therapeutics, Hegea Bio, Isabers, Meike Solar, Weishi Energy and GeneCast Biotechnology.

Last updated · Source: ConnectSafely investor database